Journal of the Korean Continence Society最新文献_第4页

Efficacy of terazosin for overactive bladder symptoms and sexual function in patients with overactive bladder and symptomatic benign prostatic hyperplasia: a prospective multicenter trial. 特拉唑嗪治疗膀胱过度活跃和症状性良性前列腺增生患者膀胱过度活跃症状和性功能的疗效:一项前瞻性多中心试验

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.36

C. Doo, M. Choo, Kyu-Sung Lee, M. Chung, K. Park, J. Paick, T. Hwang

{"title":"Efficacy of terazosin for overactive bladder symptoms and sexual function in patients with overactive bladder and symptomatic benign prostatic hyperplasia: a prospective multicenter trial.","authors":"C. Doo, M. Choo, Kyu-Sung Lee, M. Chung, K. Park, J. Paick, T. Hwang","doi":"10.5213/JKCS.2008.12.1.36","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.1.36","url":null,"abstract":"Objective: This study is to evaluate the efficacy of terazosin in the treatment of overactive bladder (OAB) symptoms and sexual dysfunction in patients with symptomatic benign prostatic hyperplasia (BPH) and OAB. Methods: Of 200 men aged 50-80 years with symptomatic BPH, an International Prostatic Symptom Score (IPSS) ≥8 accompanied by OAB symptoms, 185 patients completed treatment with terazosin 2-5 mg once daily for 8 weeks. Patients were asked to complete a voiding diary, the International Index of Erectile Function (IIEF) questionnaire, and the IPSS at baseline, 4 and 8 weeks. Results: 8-week terazosin treatment improved OAB symptoms as well as reducing IPSS (19.8 to 12.7) and IIEF (34.4 to 37.4) scores. OAB symptoms improved significantly, irrespective of symptom severity by the IPSS, but the IIEF score only increased in patients with severe symptoms. Conclusions: Additional studies are needed to further evaluate the placebo effect. However, terazosin monotherapy is effective in patients with symptomatic BPH and OAB, and may increase sexual function in patients with severely symptomatic BPH. (J Korean Continence Soc 2008;12:36-41)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"30 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"116940995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Dementia and Voiding Dysfunction. 痴呆和排尿功能障碍。

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.10

J. Choi

引用次数: 1

Female Acute Urinary Retention Caused by Urethral Diverticulum. 女性尿道憩室致急性尿潴留。

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.88

Young Joo Kim

引用次数: 0

Infective Cellulitis of Obturator Foramen and Persistent Vaginal Erosion following Transobturator tape (TOT) procedure. 经闭孔带(TOT)手术后的闭孔感染性蜂窝织炎和持续阴道糜烂。

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.78

D. Sohn, W. Bae, Ho jae Lee, Jo Un Jung, Sun Wook Kim, N. Lee, Sung Dae Kim, Yong‐Hyun Cho, S. Kim

引用次数: 1

Recognitional study about patients and caregivers' understanding of clinical trial. 患者及护理人员对临床试验认知的认知研究。

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.48

D. Kim, O. Kwon, Sang Gyung Kim, I. Shin

引用次数: 6

Initial 4 Cases Experience of Male Sling Procedure for the Treatment in Patients with Post-prostatectomy Incontinence. 男性吊带术治疗前列腺切除术后尿失禁4例体会。

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.81

D. Han, H. Jeong

引用次数: 1

The Effect of Dutasteride on Serum Prostate-specific Antigen (PSA) in Patients with Benign Prostate Hypertrophy. 杜他雄胺对良性前列腺肥大患者血清前列腺特异性抗原(PSA)的影响

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.42

Gilho Lee, J. Hong, Hyung Jee Kim

{"title":"The Effect of Dutasteride on Serum Prostate-specific Antigen (PSA) in Patients with Benign Prostate Hypertrophy.","authors":"Gilho Lee, J. Hong, Hyung Jee Kim","doi":"10.5213/JKCS.2008.12.1.42","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.1.42","url":null,"abstract":"Purpose: 5α reductase, dutasteride, has widely used to treat enlarged prostate (BPH). By suppressing the conversion of testosterone to dihydrotestosterone it decreases serum prostate-specific antigen (PSA) which is very important screening marker for prostate cancer. We evaluate the early serum PSA changes after dutasteride treatment to Korean BPH patients. Materials and Methods: A total 159 men with a clinical diagnosis of BPH and no evidence of prostate cancer were enrolled. They were treated with dutasteride 0.5mg daily for 12 months. Serum PSA was evaluated at 2, 6, and 12 months after the medication. Result: Dutasteride statistically significantly reduced serum PSA to 0.70±0.52, 0.64±0.35, and 0.59±0.49 from baseline level at 2, 6, and 12 months after the medication, respectively. However, there was no statistical significance among the three groups in serum PSA changes after dutasteride. There were statistically significant correlations between a high pre-treatment serum PSA level and a large reduction of follow-up PSA levels at 2, 6, and 12 months after dutasteride treatment. Conclusions: The reduction of serum PSA is variable in patients to patients at 2, 6, and 12 months after dutasteride treatment. The patient with high initial serum PSA revealed a large reduction of serum PSA level after treatment. The traditional concept that follow-up serum PSA level should be doubled for prostate cancer screening may overestimate real serum PSA level within 12 months in Korean men receiving 5α reductase inhibitors. (J Korean Continence Soc 2008;12:42-47)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"23 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"132050775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 4

Female Stress Urinary Incontinence 女性压力性尿失禁

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.1

Y. Park

{"title":"Female Stress Urinary Incontinence","authors":"Y. Park","doi":"10.5213/JKCS.2008.12.1.1","DOIUrl":"https://doi.org/10.5213/JKCS.2008.12.1.1","url":null,"abstract":"Stress urinary incontinence (SUI) is a significant health problem world‐wide with considerable social and economic impact on individuals and society. The initial evaluation of urinary incontinence begins with a thorough detailed history taking, physical examination including stress test and Q-tip test, and routine laboratory studies. The pelvic examination demonstrates laxity of pelvic support, presence of any degree of prolapse. A neurologic examination should be done if neuropathy is suspected. The urodynamic study can be helpful to confirm the classic features of urinary incontinence and determine its cause. Conservative managements have been used to treat stress urinary incontinence and seem to make common sense, especially in less severe and bothersome cases. Pelvic floor muscle training appeared to be an effective treatment for adult women with stress or mixed incontinence. In pharmacologic treatment, duloxetine appears to be a promising new option for the treatment of SUI. There are literally hundreds of surgical procedures used to treat incontinence, and they are consistently being revised in going attempts to improve outcomes. Burch colposuspension and sling procedures still are the main stream but recently tension‐free vaginal tape procedure and its variants are developed and widely performed all over the world. Mid‐urethral slings showed good outcomes and are safe and brief to perform and have a relatively short learning curve. Remeex system is a relatively new surgical device introduced for the cure of SUI. Its main advantage is the possibility to adjust the sling tension if urine loss or voiding difficulties manifest after surgery. TVT‐secur procedure needs only one vaginal incision and minimal periurethral dissection for small sized mesh. Therefore, it can help make the surgery quicker and simpler. As the population of aging women increases, it is inevitable that these women’s disorders will become more prevalent. This will pose a major challenge to the health care systems. (J Korean Continence Soc 2008;12:1-9)","PeriodicalId":231333,"journal":{"name":"Journal of the Korean Continence Society","volume":"4 10","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2008-06-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"120845704","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 2

The factors of pain and anxiety associated with urodynamics in female patients 女性患者尿动力学相关的疼痛和焦虑因素

Journal of the Korean Continence Society Pub Date : 2008-06-30 DOI: 10.5213/JKCS.2008.12.1.68

Kyu Kim, N. Lee, Jo Un Jung, H. Suh, Dong Hwan Lee

引用次数: 4

Clinical Outcome of Tension-free Transobturator Suburethral Tape (inside-out TVT-O) Procedure for the Treatment of Stress Urinary Incontinence: The Two Years Follow-up. 无张力经通气管下腔带(内-外TVT-O)治疗压力性尿失禁的临床效果:两年随访。

Journal of the Korean Continence Society Pub Date : 2007-12-31 DOI: 10.5213/JKCS.2007.11.2.145

Young Joo Kim, J. Huh, H. Song

引用次数: 2